Patents by Inventor Bruce A BUNNEL

Bruce A BUNNEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11357866
    Abstract: A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide or neutralizing antibody. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: June 14, 2022
    Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Stephen E. Braun, Debasis Mondal, Bruce A Bunnell, Narae Lee
  • Publication number: 20210015971
    Abstract: The present disclosure relates to surgical grafts for replacing nipples and areolas lost to disease or trauma with surgical grafts of decellularized donor nipples and areolas and to placing and recellularizing such grafts. The disclosure further provides methods for decellularizing epidermis. The decellularized epidermis can be used as a protective cover for skin wounds.
    Type: Application
    Filed: May 15, 2020
    Publication date: January 21, 2021
    Applicant: The Administrators of the Tulane Educational Fund
    Inventors: Nicholas C. Pashos, Bruce A. Bunnell
  • Patent number: 10709811
    Abstract: The present disclosure relates to surgical grafts for replacing nipples and areolas lost to disease or trauma with surgical grafts of decellularized donor nipples and areolas and to placing and recellularizing such grafts. The disclosure further provides methods for decellularizing epidermis. The decellularized epidermis can be used as a protective cover for skin wounds.
    Type: Grant
    Filed: October 31, 2015
    Date of Patent: July 14, 2020
    Assignee: The Administrators of the Tulane Educational Fund
    Inventors: Nicholas C. Pashos, Bruce A. Bunnell
  • Publication number: 20160060302
    Abstract: A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
    Type: Application
    Filed: April 3, 2014
    Publication date: March 3, 2016
    Inventors: Stephen E. BRAUN, Debasis MONDAL, Bruce A BUNNEL, Narae LEE